interleukin-6
Recombinant proteinexperimental
Interleukin 6 (IL-6) is an interleukin that acts as both a pro-inflammatory cytokine and an anti-inflammatory myokine. In humans, it is encoded by the IL6 gene. — Wikipedia
Clinical trial activity
2 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Aug 1, 2007 (NCT00470093)
Timeline
No events for the selected filters.
Mechanism of action
- Interleukin-6Supplementation
IL6 supplementation
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaInterleukin 6 ↗
Also known as
- interleukin-6
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06612476 | N/A | Sep 20, 2024 | Ningbo No. 1 Hospital |
| NCT00470093 | N/A | Aug 1, 2007 | Johns Hopkins University, National Cancer Institute (NCI) |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Johns Hopkins University | Academic/Hospital | 1 | 1 | 1 | 2007 |
| National Cancer Institute (NCI) | Government | 1 | 0 | 1 | 2007 |
| Ningbo No. 1 Hospital | Academic/Hospital | 1 | 1 | 1 | 2024 |
3 organizations
Page 1 / 1